Comprehensive coverage

October 4, 2020

Weizmann Institute of Science scientists, in collaboration with researchers from the National Cancer Institute and Ben-Gurion University of the Negev, recently found a genetic signature that differentiates between tumors that may respond to immunotherapy and tumors that are resistant to this treatment method. Besides better diagnostic tools for predicting the response of patients to immunotherapy
Studies that started with a certain direction and ended up in completely different places
Science website logo
SEARCH